Reduction in Hospital Length of Stay for Patients Requiring Lower Extremity Amputation  by Unger, Joshua et al.
intraoperative findings, and follow-up duration. The outcomes studied
were limb salvage and primary stent patency. Continuous data were
analyzed with a t test, and categoric data were analyzed with a 2 test.
Results: We identified 40 patients in the proximal stent group and
56 in the distal stent group. Follow-up imaging data were available for 82
patients. The two groups did not differ in demographics, mean number
of patent runoff vessels (proximal, 2.0 vessels; distal, 1.8 vessels; P 
.18), or mean duration of follow-up (proximal, 259 days; distal, 257
days; P  .98). Claudication was more often an indication for popliteal
stent placement in the proximal group (42% vs 16%; P  .004). Limb-
threatening ischemia was more frequently an indication for stent place-
ment in the distal group (75% vs 55%; P  .04). Limb salvage was
achieved in 92.5% of proximal and in 85.7% of distal stent placements
(P  .30). Limb salvage did not differ between the groups when only
patients with limb-threatening ischemia were included in the analysis
(proximal, 86%; distal, 83%; P  .75). Primary patency at 3 months was
57% in the proximal group vs 49% in the distal group (P  .46).
Conclusions: Popliteal artery stenting is associated with a high rate
of limb salvage at a mean follow-up of 8 months and is an acceptable
option for patients with incapacitating claudication and limb-threatening
ischemia who are poor candidates for alternative interventions. Popliteal
stents placed across the knee joint did not affect limb salvage or patency
compared with stents placed above the knee joint.
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Objective(s): Perioperative acute kidney injury (AKI) is not uncom-
mon in patients after extremity revascularization. High-density lipopro-
teins (HDL) have been shown to reduce organ injury and death in animal
models via modulation of adhesion molecules and cytokines. Our aim was
to examine the association of HDL and other factors on perioperative
AKI in patients undergoing revascularization for symptomatic chronic
limb ischemia.
Methods: All patients who underwent open or endovascular revas-
cularization between June 2001 and December 2009 for symptomatic
chronic limb ischemia (Rutherford category 3 to 6) were retrospectively
analyzed. Patients on dialysis and those with incomplete data were
excluded. Patients were grouped for HDL 40 or 40 mg/dL. Univar-
iate and multivariate analysis were used to identify factors associated with
AKI.
Results: Included were 684 patients (219 open, 465 endovascular/
hybrid) with diabetes (47%) chronic kidney disease (20%), critical limb
ischemia (31%), and 40 HDL (60%). Medications included statin use
(57%), angiotensin converting enzyme inhibitors/angiotensin receptor
blockers (53%). Postoperative AKI developed in 85 patients (12.4%),
9.4% endovascular vs 12.6% open (P  NS). The AKI group was more
likely to be older (71.5  10.1 vs 68.0  10.8 years, P  .01), have
diabetes (60% vs 46%, P .01), be using angiotensin-converting enzyme
inhibitors/angiotensin receptor blockers (64% vs 52%, P  .04), and
have pre-existing chronic kidney disease (36% vs 17%, P  .001). AKI
occurred in 16% of patients with low HDL and in 7% with high HDL
(P  .001). Multivariate analysis using logistic and propensity score
showed that HDL level (hazard ratio, 2.4; 95% confidence interval,
1.4-4.2) and underlying chronic kidney disease were independent pre-
dictors of postoperative AKI (P  .001).
Conclusions: AKI after revascularization is not uncommon (12.4%),
and lower HDL, along with chronic kidney disease, is associated with
increased odds of postoperative AKI. If these observations can be verified
in a prospective fashion, strategies for increasing HDL level in patients
with a high risk of postoperative AKI should be investigated.
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Objective(s): This study evaluated the effect of a multidisciplinary
approach and initiation of care pathways on hospital length of stay (LOS) for
lower extremity amputations.
Methods: Patients undergoing lower extremity amputations (toe,
below the knee, above the knee, or revision of prior amputation) between
January 2010 and December 2011 were retrospectively identified by
International Classification of Diseases–9th Edition codes (84.11, 84.12,
84.14, 84.15, or 84.3) in our institution’s administrative database after
obtaining Investigational Review Board approval. Midway through the
study period, in January 2011, a multidisciplinary change in care of these
patients was initiated. Among the changes made was initiation of twice-
weekly rounds with representatives from vascular surgery, limb loss
counseling, physical therapy, and a discharge coordinator. Patients’
discharge diagnoses and medical comorbidities were analyzed by All
Patient Refined Diagnosis Related Group (APR-DRG) in the University
HealthSystem Consortium (UHC) Clinical Database. LOS before and
after the change in practice was compared with similar patients in
academic institutions nationwide via the LOS index, defined as actual
LOS-to-expected LOS ratio.
Results: During the 2-year study period, 150 patients underwent 188
amputations, including 114 amputations in 2010. After the change in practice, 74
amputationswere performed in 2011. Patient demographicswere consistent across
the study period, including a72%prevalence of diabetesmellitus. AverageLOSwas
11.17.04days in 2010 anddecreased to9.616.37days in 2011 (P .0621),
without a significant change in readmission rate. The crude LOS decrease was not
statistically significant, but when adjusted for patient comorbidities, the LOS index
was significantly decreased from 1.19 0.629 in 2010 to 1.03 0.547 in 2011
(P .0365). LOS indexwas inversely related to the 30-day readmission rate (Fig).
Total savings to the hospital$150,000 for 2011.
Conclusions: A multidisciplinary partnership of physician and hos-
pital team members resulted in a decrease in LOS of 1.5 days for patients
undergoing lower extremity amputations, representing increased effi-
ciency of care and decreased observed costs.
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Objective(s):Carotid intimamedia thickness (cIMT) has been broadly
used as a surrogate measure for cardiovascular risk but is not widely available
or standardized. Our goal was to identify a set of serum biomarkers associ-
ated with cIMT independent of race and sex.
Methods: The Heart Strategies Concentrating on Risk Evaluation
(SCORE) study is a prospective community-based cohort study of 2000
adults that started enrollment in 2003. Serum biomarkers of inflammation,
metabolic, and endothelial function were obtained and examined in relation
to cIMT, which wasmeasured as a continuous variable and categorically with
a cutoff of 1 mm.
Results: cMIT was measured in 697 patients (66% white, 32% black;
62% women). Cohort demographics and comorbidities are detailed in the
Table. cIMT was positively associated with interleukin-6 (RS  0.17, P 
.0001), fasting glucose (RS 0.20, P .0001), and insulin (RS 0.14, P
.0002) levels and inversely associated with adiponectin (RS  0.20, P 
.0001), CD40L (RS  .014, P  .0003), and high-density lipoprotein
cholesterol (RS  0.20, P  .0001) levels. cIMT was not associated with
endostatin, highly-selective C-reactive protein, soluble intercellular adhe-
sion molecule, total cholesterol, low-density lipoprotein cholesterol, or
triglycerides. Multiple regression analysis identified age (partial correlation
[RP]  0.23, P  .0001), female sex (RP  0.16, P  .0001), black race
(RP  0.13, P  .0009), body mass index (RP  0.08, P  .04), serum
glucose (RP 0.14, P .0002), high-density lipoprotein cholesterol (RP
0.08, P  .03), and interleukin 6 (RP  0.07, P  .05) were indepen-
dently associated with cIMT.
Conclusions:We identified several biomarkers that are positively (interleu-
kin-6,glucose, insulin)or inversely (adiponectin,CD40L,high-density lipoprotein)
associated with cIMT. Because increased cIMT predicts cardiovascular outcomes,
examination of these clinical markers in relation to future cardiovascular events is
Fig.
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